Particle Data Platform

95 % Of Ingredients Rejected

30:4531:29 · 43s

Sam shares that their R&D team dismisses most novel ingredients because the supporting data isn’t statistically significant or clinically sound.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.